Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xiaobin Cui, Xi Chen, Weiwei Wang, Aimin Chang, Lan Yang, Chunxia Liu, Hao Peng, Yutao Wei, Weihua Liang, Shugang Li, Ning Wang, Wei Liu, Jianming Hu, Wenjie Zhang, Lidong Wang, Yunzhao Chen & Feng Li. (2017) Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry. Epigenetics 12:8, pages 698-707.
Read now
Read now
Articles from other publishers (35)
Francesco Autore, Alice Ramassone, Luca Stirparo, Sara Pagotto, Alberto Fresa, Idanna Innocenti, Rosa Visone & Luca Laurenti. (2023) Role of microRNAs in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences 24:15, pages 12471.
Crossref
Crossref
Eugenia Rastorgueva, Daria Liamina, Ivan Panchenko, Elena Iurova, Evgenii Beloborodov, Evgeniya Pogodina, Dmitrii Sugak, Sergei Slesarev & Yury Saenko. (2022) The effect of chromosome abnormalities on expression of SnoRNA in radioresistant and radiosensitive cell lines after irradiation. Cancer Biomarkers 34:4, pages 545-553.
Crossref
Crossref
Marco Morselli & Giorgio Dieci. (2022) Epigenetic regulation of human non-coding RNA gene transcription. Biochemical Society Transactions 50:2, pages 723-736.
Crossref
Crossref
Anna Grenda, Agata Filip & Ewa Wąsik‑Szczepanek. (2022) Inside the chronic lymphocytic leukemia cell: miRNA and chromosomal aberrations. Molecular Medicine Reports 25:2.
Crossref
Crossref
Ugo Testa & Elvira Pelosi. 2022. MicroRNA. MicroRNA
429
468
.
Hyun Jeong Seok, Young Eun Choi, Jae Yeon Choi, Joo Mi Yi, Eun Joo Kim, Mi Young Choi, Su-Jae Lee & In Hwa Bae. (2021) Novel miR-5088-5p promotes malignancy of breast cancer by inhibiting DBC2. Molecular Therapy - Nucleic Acids 25, pages 127-142.
Crossref
Crossref
Katerina Katsaraki, Paraskevi Karousi, Pinelopi I. Artemaki, Andreas Scorilas, Vasiliki Pappa, Christos K. Kontos & Sotirios G. Papageorgiou. (2021) MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia. Cancers 13:4, pages 593.
Crossref
Crossref
Justyna A. Wierzbinska, Reka Toth, Naveed Ishaque, Karsten Rippe, Jan-Philipp Mallm, Lara C. Klett, Daniel Mertens, Thorsten Zenz, Thomas Hielscher, Marc Seifert, Ralf Küppers, Yassen Assenov, Pavlo Lutsik, Stephan Stilgenbauer, Philipp M. Roessner, Martina Seiffert, John Byrd, Christopher C. Oakes, Christoph Plass & Daniel B. Lipka. (2020) Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL. Genome Medicine 12:1.
Crossref
Crossref
Yizhi Xiao, Side Liu, Jiaying Li, Weiyu Dai, Weimei Tang, Li Xiang, Wenjing Zhang, Jianjiao Lin, Jing Wang, Xiaosheng Wu, Guangnan Liu, Yuyang Liu, Yaying Chen, Huiqiong Zhu, Yusi Wang, Zhizhao Lin, Qiong Yang, Tianming Chen, Yong Sun, Aimin Li, Jing Xiong & Jide Wang. (2020) RETRACTED ARTICLE: The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer. Cellular Oncology 43:6, pages 1017-1033.
Crossref
Crossref
Giacomo Andreani, Giovanna Carrà, Marcello Francesco Lingua, Beatrice Maffeo, Mara Brancaccio, Riccardo Taulli & Alessandro Morotti. (2020) Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets. Cancers 12:3, pages 629.
Crossref
Crossref
Maria Tsagiopoulou, Vicente Chapaprieta, Martí Duran-Ferrer, Theodoros Moysiadis, Fotis Psomopoulos, Panagoula Kollia, Nikos Papakonstantinou, Elias Campo, Kostas Stamatopoulos & Jose I. Martin-Subero. (2020) Chronic lymphocytic leukemias with trisomy 12 show a distinct DNA methylation profile linked to altered chromatin activation. Haematologica 105:12, pages 2864-2867.
Crossref
Crossref
Felice Pepe & Veronica Balatti. (2020) Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia. Journal of Clinical Medicine 9:2, pages 593.
Crossref
Crossref
Gurvinder Kaur, Vivek Ruhela, Lata Rani, Anubha Gupta, Krishnamachari Sriram, Ajay Gogia, Atul Sharma, Lalit Kumar & Ritu Gupta. (2020) RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome. Blood Cancer Journal 10:1.
Crossref
Crossref
Charalampos Xanthopoulos & Efterpi Kostareli. (2019) Advances in Epigenetics and Epigenomics in Chronic Lymphocytic Leukemia. Current Genetic Medicine Reports 7:4, pages 214-226.
Crossref
Crossref
Ahmed Gomaa, Dunfa Peng, Zheng Chen, Mohammed Soutto, Khaled Abouelezz, Alejandro Corvalan & Wael El-Rifai. (2019) Epigenetic regulation of AURKA by miR-4715-3p in upper gastrointestinal cancers. Scientific Reports 9:1.
Crossref
Crossref
Rebecca Kohnken & Anjali Mishra. (2019) MicroRNAs in Cutaneous T-Cell Lymphoma: The Future of Therapy. Journal of Investigative Dermatology 139:3, pages 528-534.
Crossref
Crossref
Katerina Cerna, Jan Oppelt, Vaclav Chochola, Katerina Musilova, Vaclav Seda, Gabriela Pavlasova, Lenka Radova, Maddalena Arigoni, Raffaele A. Calogero, Vladimir Benes, Martin Trbusek, Yvona Brychtova, Michael Doubek, Jiri Mayer, Sarka Pospisilova & Marek Mraz. (2018) MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells. Leukemia 33:2, pages 403-414.
Crossref
Crossref
Lufang Zhang, Lushan Wang, Dong Dong, Zhiyong Wang, Wei Ji, Man Yu, Fei Zhang, Ruifang Niu & Yunli Zhou. (2018) MiR‐34b/c‐5p and the neurokinin‐1 receptor regulate breast cancer cell proliferation and apoptosis. Cell Proliferation 52:1.
Crossref
Crossref
Shama P. Kabekkodu, Vaibhav Shukla, Vinay K. Varghese, Jeevitha D' Souza, Sanjiban Chakrabarty & Kapaettu Satyamoorthy. (2018) Clustered miRNAs and their role in biological functions and diseases. Biological Reviews 93:4, pages 1955-1986.
Crossref
Crossref
Larry Mansouri, Justyna Anna Wierzbinska, Christoph Plass & Richard Rosenquist. (2018) Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact. Seminars in Cancer Biology 51, pages 1-11.
Crossref
Crossref
Claudia Consales, Claudia Cirotti, Giuseppe Filomeni, Martina Panatta, Alessio Butera, Caterina Merla, Vanni Lopresto, Rosanna Pinto, Carmela Marino & Barbara Benassi. (2017) Fifty-Hertz Magnetic Field Affects the Epigenetic Modulation of the miR-34b/c in Neuronal Cells. Molecular Neurobiology 55:7, pages 5698-5714.
Crossref
Crossref
Linlin Shao, Zheng Chen, Dunfa Peng, Mohammed Soutto, Shoumin Zhu, Andreia Bates, Shutian Zhang & Wael El-Rifai. (2018) Methylation of the HOXA10 Promoter Directs miR-196b-5p–Dependent Cell Proliferation and Invasion of Gastric Cancer Cells. Molecular Cancer Research 16:4, pages 696-706.
Crossref
Crossref
Jonathan C. Strefford, Renata Walewska & David G. Oscier. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
99
116
.
Takuya Hasegawa, Ryohei Adachi, Hitoshi Iwakata, Takayoshi Takeno, Koji Sato & Toshiyuki Sakamaki. (2017) ErbB2 signaling epigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer. FEBS Open Bio 7:8, pages 1154-1165.
Crossref
Crossref
D.‐Q. Yang, J.‐D. Zhou, Y.‐X. Wang, Z.‐Q. Deng, J. Yang, D.‐M. Yao, Z. Qian, L. Yang, J. Lin & J. Qian. (2016)
Low
miR‐34c
expression is associated with poor outcome in
de novo
acute myeloid leukemia
. International Journal of Laboratory Hematology 39:1, pages 42-50.
Crossref
Crossref
Catia Moutinho & Manel Esteller. 2017. miRNA and Cancer. miRNA and Cancer
189
220
.
Lyudmila F. Gulyaeva & Nicolay E. Kushlinskiy. (2016) Regulatory mechanisms of microRNA expression. Journal of Translational Medicine 14:1.
Crossref
Crossref
Federica Parodi, Roberta Carosio, Marco Ragusa, Cinzia Di Pietro, Marco Maugeri, Davide Barbagallo, Fabio Sallustio, Giorgio Allemanni, Maria Pia Pistillo, Ida Casciano, Alessandra Forlani, Francesco P. Schena, Michele Purrello, Massimo Romani & Barbara Banelli. (2016) Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1859:12, pages 1502-1514.
Crossref
Crossref
Mohammad Hashemi, Gholamreza Bahari, Majid Naderi, Simin Sadeghi-Bojd & Mohsen Taheri. (2016) Pri-miR-34b/c rs4938723 polymorphism is associated with the risk of childhood acute lymphoblastic leukemia. Cancer Genetics 209:11, pages 493-496.
Crossref
Crossref
Gangcan Li, Yanping Song, Yunjie Zhang, Hao Wang & Jia Xie. (2016) miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 24:2, pages 109-116.
Crossref
Crossref
Katrien Van Roosbroeck & George A. Calin. (2016) MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?. Seminars in Oncology 43:2, pages 209-214.
Crossref
Crossref
Veronica Balatti, Mario Acunzo, Yuri Pekarky & Carlo M. Croce. (2016) Novel Mechanisms of Regulation of miRNAs in CLL. Trends in Cancer 2:3, pages 134-143.
Crossref
Crossref
Musaffe Tuna, Andreia S. Machado & George A. Calin. (2016) Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases. Genes, Chromosomes and Cancer 55:3, pages 193-214.
Crossref
Crossref
Lu Qian Wang & Chor Sang Chim. (2015) DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia. Epigenomics 7:3, pages 461-473.
Crossref
Crossref
Jonathan C. Strefford. (2015) The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications. British Journal of Haematology 169:1, pages 14-31.
Crossref
Crossref